(NasdaqGM:ATON), Dover, DE and Sydney, Australia, Nov. 12, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics (Cyncado), today announced a non-binding Letter of Intent (LOI) between Australia's Asbestos and Dust Diseases Research Institute (ADDRI) and Tarus Therapeutics, LLC to conduct an […]

LOS ANGELES, Nov. 12, 2025 (GLOBE NEWSWIRE) — Transom Capital Group (“Transom”), a Los Angeles-based private equity firm specializing in operational transformation, today announced the completion of its acquisition of Binswanger Glass (“Binswanger” or the “Company”), one of the largest and most experienced full-service flat glass companies in the United States. The partnership brings new

Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) today announced that e-STORAGE, part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. (“CSI Solar”), has been contracted to provide a fully integrated energy storage solution and turnkey Engineering, Procurement, and Construction (EPC) services for the 411 MW/1,858 MWh Skyview 2 Energy Storage Project

(NasdaqGM:CLMB), EATONTOWN, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is excited to announce a strategic partnership with Liongard, a leader in asset intelligence and automation. This collaboration aims to enhance the capabilities of managed service providers

(Other OTC:OTCM),(OTC US:OTCM),(TSX-V:DMX),(Other OTC:DMXCF), NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced District Metals Corp. (TSX-V: DMX; OTCQX: DMXCF), a disciplined, science-based exploration and development company, has qualified to trade on the OTCQX(R) Best Market. District

(NASDAQ:IMTX), Company to host conference call and webcast today, November 12, at 8:30 am EST/2:30 pm CET IMA402 and IMA401 TCR Bispecifics showed favorable tolerability at RP2D as well as deep and durable responses in heavily pre-treated, last-line patients with a range of solid tumors IMA402 PRAME Bispecific at RP2D range resulted in a 30%

Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis pathology SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease remission in autoimmune diseases, with a Phase 1b trial in atopic dermatitis patients expected to begin in Q1 2026 Sitryx is proud to sponsor the 6th Inflammatory Skin Disease

Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) today announced that e-STORAGE, part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. (“CSI Solar”), has signed a Battery Energy Storage System (BESS) Supply Agreement for a 20.7 MW / 56 MWh DC energy storage project in Lower Saxony, Germany. The agreement also includes

Secures Core Technological Capabilities Through Acquisition of SK powertech,Aims to Provide Process Technology by End of 2025 – SK keyfoundry, an 8-inch pure-play foundry in Korea, announced that it is accelerating the development of SiC (Silicon Carbide)-based compound power semiconductor technology, bolstering its efforts into the global power semiconductor market. Leveraging its advanced manufacturing expertise

First clinical evaluation of BB-025, designed to rapidly and specifically reverse BB-031 activity,advancing Basking's goal to redefine thrombosistreatment- Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing the first reversible thrombolytic therapy for acute ischemic stroke (AIS), today announced that the first participants have been dosed in a Phase 1 clinical study of BB-025.BB-025 is a